scispace - formally typeset
C

C. A. Akinremi

Researcher at Federal University of Agriculture, Abeokuta

Publications -  21
Citations -  194

C. A. Akinremi is an academic researcher from Federal University of Agriculture, Abeokuta. The author has contributed to research in topics: Ligand & Chitosan. The author has an hindex of 7, co-authored 20 publications receiving 141 citations. Previous affiliations of C. A. Akinremi include University of Agriculture, Faisalabad.

Papers
More filters
Journal ArticleDOI

Biological activities of some Fluoroquinolones-metal complexes

TL;DR: The antimicrobial, toxicological and DNA cleavage studies of some synthesized metal complexes of fluoroquinolone antibiotics revealed the possibility of the metal-fluoroquolone complexes destabilizing linear double stranded DNA.
Journal ArticleDOI

Chitosan–cobalt(II) and nickel(II) chelates as antibacterial agents

TL;DR: The results indicated that inhibitory effects of the chelates were dependent not only on the property of the coordinated metal ion, but also on the molar ratio of the metal ion.
Journal ArticleDOI

Iron(III) and copper(II) complexes bearing 8-quinolinol with amino-acids mixed ligands: Synthesis, characterization and antibacterial investigation

TL;DR: In this article, four d-orbital metal complexes with mixed ligands derived from 8-hydroxyquinoline (HQ) and amino acids (AA): l -alanine and methionine have been synthesized through a mild reflux in alkaline solution and characterized by elemental analyses, infrared, electronic transition, and temperature dependant magnetic susceptibility.
Journal ArticleDOI

Toxicological studies and antimicrobial properties of some Iron(III) complexes of Ciprofloxacin

TL;DR: In this paper, two iron(III) complexes of Ciprofloxacin were synthesized by reaction of the ligand with iron (III) chloride hexahydrate in different solutions.
Journal ArticleDOI

Some nontoxic metal-based drugs for selected prevalent tropical pathogenic diseases.

TL;DR: The researchers concluded on the need for the development of MBDs to combat drug resistant parasites without causing injury to normal cells, of significance in addressing the concern World Health Organisation of ameliorating the increasing mortality rate in developing countries.